Tech was leading the way lower for stocks Wednesday. BTIG Chief Market Technician Jonathan Krinsky noted that while tech ...

BTIG raised the firm’s price target on Upwork (UPWK) to $18 from $16 and keeps a Buy rating on the shares as part of a broader research note ...

Fintel reports that on December 2, 2024, BTIG initiated coverage of BrightView Holdings (NYSE:BV) with a Buy recommendation.

Fintel reports that on December 2, 2024, BTIG downgraded their outlook for AnaptysBio (NasdaqGS:ANAB) from Buy to Neutral.

Investing.com -- According to a note from BTIG on Monday, the tech sector's ongoing weakness is raising concerns as markets ...

BTIG downgraded AnaptysBio (ANAB) to Neutral from Buy without a price target The company’s topline data from the Phase 2b trial of ANB032 in ...

Embecta (EMBC) stock gains as BTIG upgrades the stock citing an end to its patch pump program announced with its Q4 FY24 ...

Outlook Therapeutics (NASDAQ:OTLK – Free Report) had its target price reduced by BTIG Research from $50.00 to $9.00 in a ...

Ready Capital Corp (RC) stock saw a modest uptick, ending the day at $7.57 which represents a slight increase of $0.20 or 2.71% from the prior close of $7.37. The stock opened at $7.44 and touched a ...

Organogenesis Holdings Inc (ORGO) stock saw a decline, ending the day at $3.86 which represents a decrease of $-0.01 or -0.26% from the prior close of $3.87. The stock opened at $3.93 and touched a ...

BTIG lowered the firm’s price target on Outlook Therapeutics (OTLK) to $9 from $50 and keeps a Buy rating on the shares. The ...

Investors should start looking at restaurant names that have timely setups, said Jonathan Krinsky, chief market technician at ...